EMA, Guideline on the quality of water for pharmaceutical use, 07/20 Anna Sandberg2023-06-09T07:20:50+00:00September 28th, 2021|
FDA GFI, Regulatory Considerations for HCT/P Minimal Manipulation and Homologous Use, 12/17 2021-09-22T13:46:44+00:00January 17th, 2020|
FDA GFI, Current Good Tissue Practice for Manufacturers of HCT/Ps, 12/11 2021-09-22T12:40:37+00:00January 17th, 2020|
EMA Summary of the responses to the public consultation – EC 1394/2007 2023-06-09T07:18:46+00:00January 17th, 2020|
MedDev Guidance Devices utilising tissues originating from animals TSE risk 2.11/1 rev 2 2021-09-23T09:31:28+00:00January 17th, 2020|